Overall the findings in the mouse models of pure FHM support the conclusion that their increased susceptibility to experimental CSD is largely due to excessive cortical glutamatergic transmission, arising from either increased glutamate release (FHM1) or impaired glutamate clearance (FHM2). This evidence concerns the gene ATP1A2 and familial hemiplegic migraine.